ShreeOswal Seeds & Chemicals Ltd
ShreeOswal Seeds and Chemicals Ltd is a IN-based company operating in Food Products industry. ShreeOswal Seeds and Chemicals Limited is an India-based company, which is engaged in the business of production, processing, and sale of different kinds of agricultural seeds. The firm is a producer, exporter and supplier of processed mustard seeds, soyabeans, black gram, maize, wheat, Isabgol and mung. Its mustard seeds brands include Oswal Gold Plus, Oswal OSYM-55, and Oswal OSM-77. Its soyabeans brands include Oswal Super Star 211, Oswal JS9305, Oswal JS335, and Oswal JS9560. Its black gram brand is TAU-1. Its wheat brands include Oswal Lok-1, Oswal Rochak, Oswal Krishna-11, Oswal Raj-4037, and Oswal Sharbati-14001. Its Isabgol brand is Oswal 5001. The firm provides its products to pharmaceutical companies and multinational companies across the world. The firm manufactures, supplies, and exports psyllium seed husk. The firm's wholly owned subsidiary is Shreeoswal Psyllium Exports India Limited.
Price Trend & Technical Volume
Daily QuotesPrice Chart (Historical Trend)
Interactive index-style Recharts with entry animations
4V Matrix
Multi-dimensional proprietary scoreValuation Comparison
Intrinsic & Fair Value Multiples* DCF valuation criteria: 2-Stage model: 10% growth rate years 1-5, 10.5% discount rate, 3% terminal growth rate
Community Sentiment
Be the first to voteWhat is your outlook on ShreeOswal Seeds & Chemicals Ltd? Anonymous community voting — click an option to cast or update your vote.
AI Diagnostics Score
Weighted model combining fundamental, technical & growth factors.
- Debt/Equity is within safe range (1.21).
- Piotroski financial solvency score: 4/9.
- Momentum metrics indicate consolidation near key averages.
Historical Returns
Growth Analysis
| Metric | 1-Yr YoY | 3-Yr CAGR | 5-Yr CAGR |
|---|---|---|---|
| Sales | +0.9% | -3.0% | — |
| Profit | +104.7% | +8.2% | — |
Institutional Valuation Models & Fundamental Quality Methodology
DesiStocks synthesizes classical institutional valuation models and financial distress frameworks to provide a balanced, multi-dimensional view of Indian equity fundamentals. Review each methodology below to understand its core drivers, appropriate use cases, and inherent assumptions.
Projects operating cash flows minus capital expenditures over a 5-year forecast window, discounted back to present value using the Weighted Average Cost of Capital (WACC). Terminal value assumes a sustainable 4% perpetual growth rate matching India's long-term GDP expansion.
Rooted in classic value investing doctrine: √(22.5 × EPS × Book Value). Graham's formula sets a defensive price ceiling to ensure an investor never pays more than 15x earnings and 1.5x tangible book value simultaneously.
Anchored in Growth at a Reasonable Price (GARP). Equates a fair P/E multiple directly to the sustainable earnings growth rate percentage: Fair Price = EPS × Growth Rate. A PEG below 1.0 signifies potential undervaluation relative to growth.
Nine binary financial tests across profitability (positive ROA, cash flow > net income), balance sheet leverage (declining debt, rising liquidity, zero share dilution), and operational efficiency (improving gross margin and asset turnover). High scores (8–9) confirm robust quality.
Five weighted financial ratios assessing working capital, cumulative profitability, operating leverage, market capitalization, and asset turnover. Proven predictor of balance sheet stress and corporate bankruptcy probability over a 24-month horizon.
Proprietary four-pillar diagnostic framework examining Valuation (multiples vs 5Y history), Value Creation (ROCE spread over WACC cost of capital), Volatility (drawdown containment & beta), and Velocity (operating profit momentum).
All intrinsic valuations and scores are mathematical models generated using publicly available financial statements and historical market disclosures. These calculations do not represent guaranteed future price targets, investment advice, or research analyst buy/sell ratings under SEBI (Research Analysts) Regulations. Always perform independent diligence and consult a licensed financial advisor.